Dynorphin A-(1-13) and (2-13) improve β-amyloid peptide-induced amnesia in mice

NeuroReport

Volumn 11, Issue 3, 2000, Pages 431-435

  Hiramatsu, Masayuki ^a   Inoue, Kaori ^a   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Alternation behavior; Cholinergic neuronal system; Dynorphin A (1 13); Dynorphin A (2 13); Kappa opioid receptor; Non opioid; Nor binaltorphimine dihydrochloride; Amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; DYNORPHIN[1-13]; DYNORPHIN[2-13]; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LEARNING DISORDER; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034004158     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200002280-00001     Document Type: Article

References (25)

1. Chavkin C, James IF and Goldstein A. Science 215, 413-415 (1982).
2. Goldstein A, Fischli W, Lowney LI et al. Proc Natl Acad Sci USA 78, 7219-7223 (1981).
3. Caudle RM and Isaac L. Brain Res 435, 1-6 (1987).
4. Introini-Collison IB, Cahill L, Baratti CM and McGaugh JL. Psychobiology 15, 171-176 (1987).
5. Baskin DS, Hosobuchi Y, Loh HH and Lee NM. Nature 312, 551-552 (1984).
6. Itoh J, Ukai M and Kameyama T. Eur J Pharmacol 234, 9-15 (1993).
7. Itoh J, Ukai M and Kameyama T. Eur J Pharmacol 236, 341-345 (1993).
8. Hiramatsu M, Sasaki M and Kameyama T. Eur J Pharmacol 282, 185-191 (1995).
9. Hiramatsu M, Mori H, Murasawa H and Kameyama T. Br J Pharmacol 118, 255-260 (1996).
10. Hiramatsu M, Sasaki M, Nabeshima T and Kameyama T. Pharmacol Biochem Behav 56, 73-79 (1997).
11. Moises HC and Walker JM. Psychopharmacology 94, 491-495 (1988).
12. Knox RJ and Dickenson AH. Brain Res 415, 21-29 (1987).
13. Caudle KM, Chavkin C, Dubner R. J Neurosci 14, 5580-5589 (1994).
14. Hiramatsu M, Kameyama T and Nabeshima T. Carbon monoxide- induced impairment of learning, memory, and neuronal dysfunction. In: Penney DG, ed. Carbon Monoxide. Boca Raton, FL: CRC Press, 1996: 187-210.
15. Maurice T, Lockhart TP and Privat A. Brain Res 706, 181-193 (1996).
16. Pike CJ, Burdick D, Walencewicz AJ et al. J Neurosci 13, 1676-1687 (1993).
17. Hiramatsu M, Inoue K and Kameyama T. Brain Res (2000) in press.
18. Inoue K, Hiramatsu M and Kameyama T. Jpn J Pharmacol Suppl I 79, 55P (1999).
19. Haley TJ and McCormick WG. Br J Pharmacol 12, 12-14 (1957).
20. Faden AI. J Neurosci 12, 425-429 (1992).
21. Lai SL, Gu Y and Huang LY. Neurosci Lett 247, 115-118 (1998).
22. Massardier D and Hunt PF. Eur J Pharmacol 170, 125-126 (1989).
23. Hiramatsu M, Murasawa H, Nabeshima T and Kameyama T J Pharmacol Exp Ther 284, 858-867 (1998).
24. Yarygin KN, Zhang XH and Lee NM. Brain Res 791, 99-107 (1998).
25. Hoshi M, Takashima A, Noguchi K et al. Proc Natl Acad Sci USA 93, 2719-2723 (1996).